Zobrazeno 1 - 3
of 3
pro vyhledávání: '"C. Esteban Sanchez"'
Autor:
J Sala Padró, R. Jódar Masanes, M Falip Centellas, C Mariño Fernández, R Rigo Bonnin, C. Esteban Sanchez, R Juvany Roig
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: Levetiracetam (LEV) is a second-generation antiepileptic drug used as a unique or adjunctive therapy for treating partial or generalised epilepsy. Its maximum dose according to the summary product is 3000 mg/day. In patients with resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5afeeaa183da6a0f1249b6d60024c923
https://doi.org/10.1136/ejhpharm-2018-eahpconf.265
https://doi.org/10.1136/ejhpharm-2018-eahpconf.265
Autor:
M. Colls-Gonzalez, C. Esteban-Sanchez, T. Lozano-Andreu, J. Llop-Talaveron, Maria B. Badia-Tahull, A. Suarez-Lledo, Elisabet Leiva-Badosa
Publikováno v:
Clinical Nutrition. 36:S79
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6db8d4623d32738a24a0452a7bb2e1fa
https://doi.org/10.1016/s0261-5614(17)30558-7
https://doi.org/10.1016/s0261-5614(17)30558-7
Autor:
C Mariño Fernández, E. Leiva Badosa, M. Badia Tahull, C. Esteban Sanchez, J. M. Llop Talaverón, N. Sanmarti Martinez
Publikováno v:
Clinical Nutrition. 35:S112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b738127102f3d9ebfbd24d4f1d00082
https://doi.org/10.1016/s0261-5614(16)30526-x
https://doi.org/10.1016/s0261-5614(16)30526-x